Computer-assisted avatar-based treatment of dysfunctional beliefs in migraine patients: A randomized controlled trial

Computer-assisted avatar-based treatment of dysfunctional beliefs in migraine patients: A randomized controlled trial - MAS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033893

Enrollment

Registered

2024-03-15

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43

Interventions

Group 1: Intervention group: Each subject is presented with 3 individual dysfunctional thoughts in writing, which are identified and derived using the PCS questionnaire. The subjects are asked to form

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Reported migraine diagnosis and validated using the ICHD-3 criteria; minimum 4 headache days/month

Exclusion criteria

Exclusion criteria: Revoking the declartion of consent; drug-/ alcohol consumption; uncorrected visual or hearing impairment; psychotic symptoms; cognitive disorders that negatively affect learning (e.g. dementia)

Design outcomes

Primary

Measure	Time frame
Pain Catastrophizing Scale (PCS) score at baseline, post-treatment, after six weeks (PCS-3)	—

Secondary

Measure	Time frame
SECONDARY: Conviction rating of dysfunctional thoughts (rating scale 0-10); HIT-6 (Headache Impact Test) Pain intensity (visual analog scale); Number of days with attacks (last 4 weeks) number of days with acute medication (last 4 weeks) DASS (Depression Anxiety Stress Scales) TERTIARY: FAMI (Fear of Attacks in Migraine Inventory) HMSE-G-SF (Headache Management Self-Efficacy Scale - short form) FSK (pain-related locus of control questionnaire)	—

Measure

Time frame

SECONDARY: Conviction rating of dysfunctional thoughts (rating scale 0-10); HIT-6 (Headache Impact Test) Pain intensity (visual analog scale); Number of days with attacks (last 4 weeks) number of days with acute medication (last 4 weeks) DASS (Depression Anxiety Stress Scales) TERTIARY: FAMI (Fear of Attacks in Migraine Inventory) HMSE-G-SF (Headache Management Self-Efficacy Scale - short form) FSK (pain-related locus of control questionnaire)

—

Countries

Germany

Contacts

Public ContactYoussef Shiban

PFH Göttingen

shiban@pfh.de+49 551 54700 477

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026